Viteyes AREDS 2 Advanced (3 Month Supply)

Viteyes AREDS 2 Advanced is based on the findings from the AREDS 2 study. This quality formula uses natural vitamin E, FloraGLO® Lutein and OPTISHARPTM Zeaxathin. In addition, Viteyes AREDS 2 Advanced is formulated with bilberry, grape seed, selenium, alpha-lipoic acid and additional zeaxanthin. Completed in 2013, AREDS 2 was a 5-year follow-up study by the National Eye Institute (NEI) of the original AREDS study, resulting in new recommendations for AMD.* AREDS 2 Results: Omit Beta-Carotene, Add Lutein & Zeaxanthin: AREDS 2 participants who took lutein and zeaxanthin and no beta-carotene reduced their risk of developing advanced stages of AMD by 18% compared to those in AREDS 2 who took the original AREDS supplement with beta-carotene. As a result, the NEI's AREDS 2 suggests modifying the AREDS formula by omitting beta-carotene and adding lutein and zeaxanthin. Zinc Levels: In the original AREDS study, the dose for zinc was set high (80 mg) because a previous small trial had found that high-dose zinc was beneficial for AMD. However, some nutritionists were concerned the dose was too high.* The AREDS 2 study tested zinc at 80 mg and 25 mg. The results showed that when lowering zinc there was "no statistically significant effect on progression to advanced AMD."** Viteyes AREDS 2 Advanced contains the following formula: Vitamin C 500 mg, Vitamin E 400 IU, Zinc 25 mg, Copper 2 mg, Lutein 10 mg, Zeaxanthin 3.5 mg, Selenium 100 mcg, Bilberry 20 mg, Grape Seed 25 mg, and ALA 25 mg. (*NEI website 2013. AREDS 2 Media Q&A http://www.nei.nih.gov/areds2/MediaQandA.asp **AREDS2 Research Group. "Lutein/Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Controlled Randomized Clinical Trial." JAMA, published online May 5, 2013.) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.